
Anavex: A Small Bit Of Progress Against Alzheimer's Disease
Anavex's blarcamesine appears to slow cognitive decline in Alzheimer's disease, with varying results compared to donepezil. This possibly could lead to conditional approval in Europe. Sigma-1 receptor agonists like blarcamesine and Aricept slow …